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Abstract: We conducted a pilot study to evaluate the accuracy of a custom built non-contact
pressure-sensitive device in diagnosing obstructive sleep apnea (OSA) severity as an alternative to
in-laboratory polysomnography (PSG) and a Type 3 in-home sleep apnea test (HSAT). Fourteen
patients completed PSG sleep studies for one night with simultaneous recording from our
load-cell-based sensing device in the bed. Subjects subsequently installed pressure sensors in their
bed at home and recorded signals for up to four nights. Machine learning models were optimized to
classify sleep apnea severity using a standardized American Academy of Sleep Medicine (AASM)
scoring of the gold standard studies as reference. On a per-night basis, our model reached a correct
OSA detection rate of 82.9% (sensitivity = 88.9%, specificity = 76.5%), and OSA severity classification
accuracy of 74.3% (61.5% and 81.8% correctly classified in-clinic and in-home tests, respectively).
There was no difference in Apnea Hypopnea Index (AHI) estimation when subjects wore HSAT
sensors versus load cells (LCs) only (p-value = 0.62). Our in-home diagnostic system provides
an unobtrusive method for detecting OSA with high sensitivity and may potentially be used for
long-term monitoring of breathing during sleep. Further research is needed to address the lower
specificity resulting from using the highest AHI from repeated samples.
Keywords: automated obstructive sleep apnea diagnosis; unobtrusive obstructive sleep apnea
diagnosis; Apnea-Hypopnea Index; contact-less load cell sensor; long-term breathing monitoring
1. Introduction
Obstructive Sleep Apnea (OSA) is a prevalent medical condition that occurs when the upper
airway becomes blocked repeatedly during sleep causing breathing to slow or completely stop. It is
estimated that approximately 15% of the population suffers from OSA [1,2], but despite its prevalence
many clinically significant cases remain undiagnosed [3,4]. The gold standard for a definitive diagnosis
of OSA is overnight polysomnography (PSG) testing [5]. PSG is carried out at a sleep clinic where
patients spend the night with multiple sensors attached to their body to measure physiologic metrics,
including airflow, respiratory effort, blood oxygen saturation levels, electrical brain activity, eye
movement, muscle activity, electrical heart activity, and snoring. These signals are analyzed by a trained
clinician in order to detect the presence and duration of apnea and hypopnea events. However, there
is a scarcity of specialized clinics and trained professionals that are available to diagnose OSA, which
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leads to a significant percentage of people with OSA who are undiagnosed and thus untreated [2].
Furthermore, PSG is an obtrusive sleep test that can directly interfere with sleep. This negative impact
on sleep can lead to the well-known “first night effect” [6], whereby the sleep apnea detected on the
first night of PSG measurements is different than on subsequent nights as the patient gets accustomed
to the sensors.
Recently, in-home sleep apnea testing (HSAT) has become more common. HSAT uses a reduced
set of sensors that are worn on the face and chest of the patient for use at home. However, the sensors
used within HSAT, while less invasive than PSG, are still obtrusive and may interfere with a person’s
normal sleep. Furthermore, people who use HSAT are required to monitor and sustain the adequate
position and contact of sensors to obtain useful diagnostic data. People do not recognize sensor
loss while asleep and may not notice when awake in order to address signal loss, which can lead to
failed diagnoses.
OSA severity, detected using either PSG or HSAT, is measured using the Apnea Hypopnea Index
(AHI), which is the average number of apnea and hypopnea events measured over the total sleep time.
Clinically, an AHI value less than five events/h is considered normal as supported by epidemiological
evidence that showed a minimal impact on health outcomes for this many events per h. An AHI of
5–14 events/h is classified as mild sleep apnea, 15–29 events/h is moderate, while an AHI greater than
29 events/h is severe [5]. Patients with mild apnea have a wider variety of options, and the course of
treatment depends on the presence of OSA related symptoms, including sleepiness, impaired cognition,
mood disorders, or cardiovascular morbidity. However, for patients with moderate-to-severe OSA,
corresponding to an AHI > 15 events/h, nasal continuous positive airway pressure (CPAP) is often the
gold standard treatment [7–10].
Various research groups have developed sleep monitoring and diagnostic devices that are both
unobtrusive and accurate. For instance, Brink et al. [11] employed load cells (LCs) to measure basic
sleep physiology parameters, including heart rate, respiration rate, and body movements, during
sleep. Austin et al. [12] and Beattie et al. [13,14] studied the use of LCs placed under the supports of
a bed to distinguish periods of sleep and wakefulness (with sensitivity of 0.808 and specificity of 0.812),
detect respiration signals and measure its rate (with mean error of 0.18 breaths/min), and identify
clinically relevant breathing disturbances, such as apneas and hypopneas. In recent work published by
Beattie et al. [15], the main objective was to evaluate the correlation between manually scored PSG and
LC sleep study scores, which was found to be 0.97. The reported OSA detection sensitivity for a cutoff
AHI > 5 events/h was 84.0%.
Ultrasound technologies have also been used for capturing breathing signals and for diagnosing
sleep disordered breathing conditions as an alternative to obtrusive PSG and HSAT tests. Arlotto
et al. [16] designed a low-power ultrasonic Doppler device that measures the frequency shift produced
by the velocity difference between the exhaled airflow and the ambient environment and accurately
captures a breathing signal that is analyzed to detect changes in its intensity and rate. However, to the
best of our knowledge, this approach has not been clinically tested on multiple subjects.
While there are a plethora of smartphone based applications which claim to detect sleep apnea,
many of these have not yet been clinically evaluated [17]. Nandakumar et al. [18] used ultrasound
emitted from the speaker of a smartphone and measured by the onboard microphone to capture chest
movement to classify AHI severity achieving an average error of 1.9 events/h.
In the current study, we assess the diagnostic accuracy of a novel AHI measurement system
designed in our laboratory at Oregon Health and Science University (OHSU) [19]. We present accuracy
results obtained both within a monitored sleep clinic and under free living conditions in patients’
homes. The system is comprised of an array of multiple LCs arranged on a rectangular metallic plate
that is placed underneath the patient’s mattress. The system includes signal processing and machine
learning algorithms that are able to (1) extract the relevant breathing and movement-related signals
and (2) process these signals with a decision tree and linear regression algorithm to classify OSA
severity. Previously developed LC-based monitoring systems with LCs positioned under the bed
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or integrated in the bedframe require installation by a trained technician. In contrast, our system is
easily deployable at home by the patient. Moreover, we automatically process LC signals to diagnose
OSA, so that manual scoring by a technician is not required. We show the performance of our sensing
device across data collected in the sleep lab when patients wore PSG sensors, in-home data when
patients wore HSAT sensors, and also in-home data when patients did not wear HSAT sensors when
presumably we would capture more of a typical night of sleep.
This paper makes several contributions beyond what we had previously published [19]. First,
we present the analysis of the accuracy of our sensing device against gold standard PSG and HSAT
tests, which shows that our sensing system and the proposed automated signal processing pipeline
achieved high sensitivity in detecting the presence and severity of OSA in-clinic and in-home settings.
Second, we evaluate the effect of wearing HSAT sensors on the AHI estimated by our system, where we
found that there was no statically significant difference between the average AHI during the nights the
participants wore HSAT sensors versus the nights when they did not wear additional HSAT sensors.
Finally, we present the results of a usability survey that allow us to demonstrate the deployability of
the systems in unattended home settings in terms of ease of installation and effect on bed stability and
comfort during the home sleep test.
2. Materials and Methods
2.1. Cohort and Sleep Studies
Fourteen subjects (11 females and 3 males) from the OHSU sleep clinic were recruited to participate
in a pilot study in order to evaluate our sensing device in terms of its accuracy in estimating AHI
and diagnosing OSA severity. All subjects gave their informed consent for inclusion before they
participated in the study. The protocol of the study was approved by the OHSU institutional review
board (IRB), under project identification code IRB00006308 and conducted in accordance with OHSU
IRB policies and procedures.
The average age was 48 ± 21 years and the average body mass index was 33.49 ± 7.83 Kg/m2.
All participants were scheduled for in-clinic overnight diagnostic PSG, two consecutive nights of
in-home testing with HSAT sensors, and two consecutive nights of in-home sleep apnea testing with no
HSAT sensors. Figure 1 presents a flow chart of subjects who underwent sleep studies. Physiological
signals of interest were acquired and recorded using Cadwell Easy III PSG and ApneaTrak HSAT
systems (Cadwell, Kennewick, WA, USA) during in-clinic and in-home sleep studies, respectively.
While the study was designed to collect two nights of HSAT data per subject, technical problems
with the ApneaTrak arose for various reasons and for some of the subjects, only one night of in-home
HSAT data were collected. LC sensor signals were simultaneously recorded during every night of
the study using an array of contact-free LCs located underneath the patient’s mattress. PSG and
HSAT studies were scored by a registered polysomnographic technologist (RPSGT) expert and blindly
reviewed by a board certified sleep specialist according to American Academy of Sleep Medicine
(AASM) scoring guidelines [20]. The AASM recommended hypopnea scoring rule requiring a 3%
desaturation or arousal for inclusion of hypopnea was used. The calculated AHI was then used as
ground truth to optimize machine learning models for automated detection of OSA and classification
of the disease severity.
Participants were given a brief survey at the conclusion of the in-home portion of the study,
whereby they were asked how easy it was to install the system, (2) how stable the bed felt while
sleeping with the system installed, and (3) whether the bed felt comfortable while they were sleeping
with the LC system installed. The survey was scored on a 1–5 basis, whereby 5 was the best score.
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Patients scheduled for in-clinic and in-home sleep studies
N = 14
In-clinic sleep studies
N = 14
In-clinic sleep studies
N = 14
Simultaneous in-
clinic sleep testing
Cadwell Easy III and 
Load Cells
N = 14
Simultaneous in-home sleep 
testing
Cadwell ApneaTrack and Load Cells
N = 14
Night 1
Successful 
recordings
N = 13
Patient spent the 
entire night awake 
(N = 1)
Normal: N = 5
Mild: N = 6
Moderate/Severe: N = 2
Load Cells sleep studies
Load Cells only
N = 14
Night 1
Successful 
recordings
N = 14
Normal: N = 7
Mild: N = 3
Moderate/Severe: N = 4
Night 2
Successful 
recordings
N = 8
Technical issues 
with ApneaTrack
(N = 6)
Normal: N = 5
Mild: N = 2
Moderate/Severe: N = 1
Night 3
Successful 
recordings
N = 12
Normal: N = 5
Mild: N = 6
Moderate/Severe: N = 1
Night 4
Successful 
recordings
N = 12
Corrupted signals 
from load cells
(N = 2)
Normal: N = 6
Mild: N = 6
Moderate/Severe: N = 0
Figure 1. Flow chart of patients who underwent sleep studies.
2.2. Data Acquisition System
A novel contact-free sensing device, located underneath the patient’s mattress, developed in our
laboratory at OHSU was employed to capture breathing and movement signals at a sampling rate
of 250 Hz (see Figure 2). Simultaneously, data were collected from PSG and HSAT sensors (nasal
cannula and abdomen belt were employed) attached to the patient’s body. Our sleep monitoring
device was built by integrating ultra-low profile LCs (Detail-Tec, Changsha, China) into four custom
3D printed enclosure subassemblies affixed in a rectangular metallic plate. The distribution of the
subassemblies within the aluminum plate was such that two cells would register the weight on either
side of the body across the shoulders and the other two cells would target the weight in the hip. A more
detailed description of the design and fabrication of the LC-based acquisition system was provided in
our previously published work [19]. The data collected from the LCs was relayed to an Odroid-U3
processor (Samsung Electronics Co. Ltd., Suwon, Korea) via a serial peripheral interface (SPI) bus.
The Odroid formatted the data and then sent it to a Google Drive (Google, Mountain View, CA, USA)
cloud location for offline processing. Scientific libraries for Python 3.6.3, including Numpy, Scipy,
Scikit-learn, Pandas, and Matplotlib, were employed for signal processing and training of machine
learning algorithms on a Linux environment. Figure 3 presents an example of the signals obtained
from our device. In its current, our LC-based system is not designed to identify individual apnea or
hypopnea events, but the signals are processed to make it possible to estimate AHI, which is ultimately
employed to classify OSA severity in clinical practice.
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Figure 2. Oregon Health and Science University (OHSU)’s custom built data acquisition system.
Figure 3. Examples of signals obtained from our load cell (LC)-based sensing device.
2.3. Load Cells Signal Processing and Feature Extraction
Raw pressure signals from each of the four LC subassemblies were combined by adding
time-aligned samples from the four subassemblies. The resulting signal was then processed using
a band-pass filter to eliminate low frequencies corresponding to signal drift and high frequencies
greater than 5 Hz corresponding to non-physiologic noise harmonics. Next, the resulting signal was
scaled to have zero mean and unit standard deviation. The Fast Fourier Transform (FFT) was used
to calculate the power spectral density (PSD) of the processed LC signal and statistical moments
within consecutive non-overlapping frequency sub-bands of 0.02 Hz width were computed in order to
characterize the distribution of the magnitude of Fourier coefficients [19].
Using analysis of variance (ANOVA) and F-test, the skewness and kurtosis from six frequency
sub-bands were selected as the most relevant descriptors to be used to model the severity of OSA
using all the available data. These features had the highest F-score when analyzed against the
target severity categories (normal, mild, and moderate/severe). The selected frequency bands are
as follows: 0.06–0.08 Hz, 0.36–0.38 Hz, 0.96–0.98 Hz, 1.18–1.20 Hz, 1.40–1.42 Hz, and 1.68–1.70 Hz
(Mosquera-Lopez et al., 2018). Figures 4 and 5 show the distribution of features extracted from relevant
frequency sub-bands grouped by OSA severity. The box plots show the median value of the features
for all subjects within a given OSA severity category, as well as the interquartile range.
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Figure 4. Statistical distribution of spectral features used for obstructive sleep apnea (OSA) detection
grouped by clinical category.
Figure 5. Statistical distribution of spectral features used for Apnea Hypopnea Index (AHI) estimation
grouped by clinical OSA severity.
2.4. Machine Learning Models
We developed a two-stage classifier to automatically detect OSA and classify its severity.
Our previous work [19] discusses the architecture of the classification system. In order to
assess the generalization performance of the developed algorithms, we used leave-one-patient-out
cross-validation. That is, all data collected for a given subject over multiple nights irrespective of the
gold standard sleep test were held out from the training set when predicting OSA severity for the
subject. This validation strategy is advantageous when the dataset size is small because the bias is
reduced as each cross-validated model is trained almost on the entire dataset.
Our classification method, trained using spectral features presented in Table 1, is comprised
of two models: (1) stage-one decision tree (S1DT) and (2) stage-two linear regression model (S2LR).
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The goal of the first stage is to distinguish between subjects with normal and abnormal LC-based sleep
tests. The second stage of the algorithm uses linear regression to identify the actual AHI of the people
identified to have sleep apnea by the S1DT.
The linear regression model was trained on only mild, moderate, or severe sleep apnea data sets.
This linear regression model was used to predict AHI values. We found linear correlation between the
extracted features and the AHI score in the available data. Therefore a more complex model was not
necessary to process our data. However, more sophisticated machine learning methods might be useful
when processing data collected from a larger study. The predicted AHI output of the linear regression
model was subsequently used to classify the OSA severity as either mild or moderate/severe. Sleep
tests with estimated AHI values between 5–15 events/h were assigned to the mild category, whereas
sleep tests with estimate AHI values greater than 15 events/h were placed into the moderate/severe
category [21]. Cases of moderate and severe OSA were considered a single class due to the fact that
both severity levels are clinically managed using similar therapeutic approaches, CPAP being the
gold standard treatment [7–10]. The following equation defines the multiple linear regression model
optimized for AHI estimation where X[2], X[3], and X[5] are defined in Table 1:
AHI
predicted
= 11.94 + 23.06X[2]2 + 8.74X[3]− 15.04X[5]. (1)
Table 1. Spectral features used for OSA severity classification. S1DT = stage-one decision tree;
S2LR = stage-two linear regression model.
Feature Frequency Sub-Band Statistic Calculated from Fast Fourier Transform (FFT) Coefficients Classification Stage
X[1] 0.06–0.08 Hz kurtosis S1DT
X[2] 0.36–0.38 Hz skewness S2LR
X[3] 0.96–0.98 Hz skewness S2LR
X[4] 1.18–1.20 Hz kurtosis S1DT
X[5] 1.40–1.42 Hz kurtosis S2LR
X[6] 1.68–1.70 Hz skewness S1DT
Since we obtained data from the LC sensors across multiple nights for most subjects, we selected
the highest predicted AHI across both nights as the estimated AHI. It is known that there is high
night-to-night variability of OSA and there is a tendency for physicians to err on the side of higher
AHI estimations.
We also investigated whether the AHI estimation was influenced by the use of the HSAT
equipment worn by the participants. We recorded LC signals corresponding to one or two additional
nights in which subjects were sleeping at home and were not monitored with the HSAT system.
When analyzing the LC signals recorded concurrently with a gold standard method, we excluded
the portions of the recordings marked as invalid by the clinician who scored the studies based on the
gold standard signals. Since we did not have a gold standard for those additional nights in which
the participants were only monitored using our developed sensing device, we excluded the portions
of the recorded signals that were not suited for AHI estimation by using a windowed approach,
whereby overlapping 3-h recording segments were processed using our machine learning models.
For each segment, we estimate the AHI and the resulting AHI time series was processed using a rolling
median filter to detect and remove AHI outliers. Values with large deviation from the median of the
time-ordered AHI sequence might indicate the presence of noise in the evaluated portion of the study
and were therefore removed. The final AHI assigned to the study was calculated as the average of
the remaining AHI values after outlier removal. We selected a 3-h window size since a minimum of
2- to 4-h recording is recommended by AASM when testing for OSA using in-laboratory PSG and
HSAT [20].
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3. Results
We evaluated our prediction models on 13 PSG recordings corresponding to a single in-clinic
sleep test and 22 HSAT recordings corresponding to one or two overnight sleep studies per subject (see
Figure 1). The average duration of interpretable portions of PSG studies was 5.73 ± 2.15 h per night
whereas the average duration of interpretable portions of HSAT studies was 5.37 ± 2.82 h per night.
Tables 2 and 3 show the results for the categorization of sleep apnea severity and the estimated AHI
values for patients who tested positive for sleep apnea during PSG and HSAT studies, respectively.
Based on the results from all individual overnight sleep studies, including studies carried out in
the sleep clinic and at patients’ homes, S1DT reached an overall OSA detection accuracy of 82.9%
with sensitivity of 88.9% and specificity of 76.5%. The positive predictive value (PPV) and negative
predictive value (NPV) are 80.0% and 86.7%, respectively. When the accuracy analysis was performed
for studies carried out at the sleep clinic and at home separately, the S1DT correct detection rate
is calculated to be 69.2% for in-clinic studies (with sensitivity = 75.0%, specificity = 60.0%, PPV =
75.0%, and NPV = 60.0%), and 90.9% for in-home studies (with sensitivity = 100.0%, specificity =
83.3%, PPV = 83.3%, and NPV = 100.0%). The final OSA severity classification accuracy evaluated
using the combined predictions from S1DT and S2LR was calculated to be 74.3%, corresponding to
61.5% and 81.8% correctly classified in-clinic and in-home tests, respectively, with underline median
absolute AHI error of 4.59 events/h. The accuracy difference in OSA diagnosis between in-clinic
and in-home studies might be explained by the amount of data available for the estimation of final
OSA diagnosis since a single night of data was available for in-clinic studies while generally two
nights were used for in-home OSA severity classification. The average AHI estimated by the sleep
clinician from manual PSG and HSAT scoring across all subjects and nights was 14.25 ± 8.70 events/h.
The overall correlation between estimated AHI and reference AHI values was assessed using the
Pearson’s correlation coefficient, which was calculated to be 0.47 (Figure 6). This correlation is affected
by the large estimation error on a single sleep test whose true AHI score is larger than the 3-sigma
cutoff value AHI = 40.35 events/h. Figure 5 shows the extreme data point at actual AHI = 73.43
(predicted AHI = 15.32).
Table 2. Results of in-clinic overnight attended polysomnogram.
Patient ID
Study Duration Clinical Category AHI Severity
(hours) Actual Predicted Actual Predicted Actual Predicted
1 7.10 Abnormal Abnormal 7.16 6.53 Mild Mild
2 0.00 - - - - - -
3 1.15 Abnormal Abnormal 31.81 30.40 Severe Moderate/Severe
4 6.34 Abnormal Abnormal 9.12 6.01 Mild Mild
5 1.12 Abnormal Abnormal 73.43 15.32 Severe Moderate/Severe
6 7.33 Normal Abnormal 3.60 9.92 Normal Mild
7 5.16 Abnormal Normal 5.34 <5 Mild Normal
8 7.04 Normal Abnormal 4.89 9.37 Normal Mild
9 5.65 Normal Normal 3.06 <5 Normal Normal
10 6.93 Normal Normal 2.20 <5 Normal Normal
11 6.21 Abnormal Abnormal 12.11 10.30 Mild Mild
12 7.07 Abnormal Abnormal 5.20 20.06 Mild Moderate/Severe
13 6.01 Abnormal Normal 7.06 <5 Mild Normal
14 7.39 Normal Normal 0.83 <5 Normal Normal
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Table 3. In-home unattended sleep apnea testing using HSAT + LCs.
Patient ID Night
Study Duration Clinical Category AHI Severity
(hours) Actual Predicted Actual Predicted Actual Predicted
1 1 7.76 Abnormal Abnormal 9.63 9.38 Mild Mild2 9.08 Abnormal Abnormal 10.07 8.66
2 1 6.93 Abnormal Abnormal 17.46 7.05 Moderate Mild2 5.35 Abnormal Abnormal 16.16 9.71
3 1 3.56 Abnormal Abnormal 12.49 10.51 Moderate Moderate/Severe
4 1 8.15 Normal Normal 3.61 <5 Normal Normal2 5.37 Normal Normal 1.51 <5
5 1 4.83 Abnormal Abnormal 31.42 23.23 Severe Moderate/Severe
6 1 5.07 Normal Abnormal 4.42 9.12 Normal Mild2 0.77 Normal Normal 1.34 <5
7 1 5.00 Abnormal Abnormal 5.70 13.19 Mild Mild2 1.40 Abnormal Abnormal 5.07 10.20
8 1 8.57 Abnormal Abnormal 5.11 8.53 Mild Mild
9 1 1.54 Normal Normal 4.02 <5 Normal Mild2 1.45 Normal Abnormal 1.40 7.48
10 1 9.59 Normal Normal 1.49 <5 Normal Normal2 9.05 Normal Normal 2.14 <5
11 1 3.03 Normal Normal 1.67 <5 Normal Normal
12 1 2.82 Normal Normal 2.17 <5 Normal Normal
13 1 4.26 Abnormal Abnormal 18.87 18.87 Moderate Moderate/Severe
14 1 8.70 Normal Normal 0.71 <5 Normal Normal2 5.88 Normal Normal 0.18 <5
1 
 
 
Figure 6. Actual AHI versus predicted AHI. Pearson’s R = 0.47 (polysomnography (PSG) vs.
LC: R = 0.37, home sleep apnea test (HSAT) vs. LC: R = 0.74).
We also investigated the effect of wearing HSAT sensors versus not wearing HSAT sensors on
the estimated OSA severity. We compared the estimated AHI values obtained during two nights
where patients were monitored simultaneously by HSAT and LC equipment (Table 3) against AHI
obtained from LC recordings collected during two night in which subjects did not wear HSAT sensors
(Table 4). We found that when participants wore the HSAT equipment while sleeping, it did not have
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a significant effect in AHI estimation. When we compared the AHI estimation for the two nights
when participants wore the HSAT equipment with the two nights when they did not wear the HSAT
equipment, we found that there was no statistically significant difference in the AHI estimation (t-value
= −0.51, p-value = 0.62). Table 5 shows results of the survey given to the participants. Most of the
participants found the system easy to install and found that the bed felt stable and comfortable while
the LC system was installed.
Table 4. Estimated AHI when monitoring patients at home with LCs device only.
Patient ID Night
Clinical Category AHI Severity
Predicted Predicted Predicted
1 1 Abnormal 14.082 Abnormal 9.47 Mild
2 1 Abnormal 10.382 Abnormal 11.52 Mild
3 1 Abnormal 6.942 Normal <5 Mild
4 1 Abnormal 5.612 Normal <5 Mild
5 1 Abnormal 8.552 Abnormal 14.72 Mild
6 1 Normal <52 Abnormal 6.63 Mild
8 1 Abnormal 13.072 Normal <5 Mild
9 1 Normal <52 Normal <5 Normal
10 1 Normal <52 Abnormal 5.27 Mild
12 1 Abnormal 24.842 Normal <5 Severe
13 1 Normal <52 Abnormal 9.00 Mild
14 1 Normal <52 Normal <5 Normal
Table 5. LCs deployability and comfort survey results. Most respondents found the system easy to
install and did not notice any problems with stability or the comfort of the bed.
Rating * Ease of installation Stability Comfort
1 0.00% 0.00% 0.00%
2 7.14% 0.00% 0.00%
3 7.14% 0.00% 0.00%
4 28.57% 14.29% 14.29%
5 57.14% 85.71% 85.71%
* 5 is the best possible rating.
4. Discussion
This study demonstrates the feasibility of diagnosing OSA using an easy-to-install pressure
sensing device coupled with signal processing and machine learning algorithms that automatically
process pressure signals and classify OSA severity in unattended settings, either in the sleep clinic
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or at the patient’s home. Using the PSG in the sleep clinic and Type 3 HSAT systems in the home
as reference, our LC-based system had a high OSA detection accuracy. The Bland–Altman plot in
Figure 7 shows that the prediction algorithm had a bias of 2.06 events/h and an agreement range from
−25.53 to 29.69 events/h, with most AHI differences falling within the range −12.41 to 10.64 events/h.
The bias and agreement bands are influenced by the large error in the estimation of the AHI for
a single subject from a PSG test conducted in the sleep clinic whose actual AHI is beyond the 3-sigma
range as discussed under the Results section. The underestimation of AHI for the severe subject
with an AHI of 73.43 events/h was likely caused by the distribution of AHI scores within the small
cohort of participants in the study. Despite this large AHI estimation error, that PSG study was
accurately estimated to be in the moderate/severe category by our method. A more robust approach
for an accurate AHI estimation would have been the detection and counting of individual apneas
and hypopneas, which is still a challenging engineering problem that can be solved using more
sophisticated machine learning models that require large amounts of data annotated by multiple
specialized sleep clinicians to account for inter-rater variability.
Figure 7. Bland–Altman plot for assessing agreement between LCs AHI and manual scoring of gold
standard PSG and HSAT studies.
Although one night of sleep testing is the standard for diagnosis of OSA, the accuracy of OSA
detection with only one-night of testing requires high sensitivity of the test method and a stable disease
of interest to warrant a low rate of false-negative tests [22,23]. For people with OSA, there can be
a large night-to-night variability, including extreme OSA on one night and normal (i.e., very little OSA)
another night. This night-to-night variability may be due to the subject’s lying position or the duration
of rapid-eye movement (REM) during sleep. In practice, one night supine can provide completely
different test results than one night lateral for some subjects. Therefore, monitoring a patient’s sleep
over multiple nights might provide a more sensitive OSA detection test. In this study, using the
available data collected during multiple nights (including LC signals obtained in the sleep clinic and
at home), and selecting the most severe night as the final OSA severity, we found that all subjects with
OSA were correctly identified by our proposed LC-based system (sensitivity = 100.0%). However,
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our method tends to overestimate the severity of OSA (specificity = 50.0%) in accordance with the
confusion matrix in Figure 8.
Figure 8. Confusion matrix for OSA severity classification from multiple nights, including in-clinic
and in-home studies, with reference AHI.
The diagnosis of sleep apnea is given for an AHI > 5. Mild to moderate OSA is indicated for an
AHI of 5 to 14 yet sensitivity and specificity of our gold standards (PSG and HSAT) used in this study
break down when different approved scoring criteria are used or when comparing home sleep apnea
testing to PSG. For the in-home portion of the study, the LC-based system tended to over-estimate
AHI compared with the HSAT system. It is important to consider that the HSAT system did not
include EEG sensors that are typically used to obtain a more accurate AHI score. In the future, we
will further investigate whether the overestimation of OSA by our sensor system still occurs when
we use a more accurate gold standard method for obtaining AHI that includes EEG within the HSAT
system. We found that OSA severity overestimation was more prevalent when comparing LC against
HSAT results compared with the OSA PSG done in the lab. Other groups have also found that HSAT
systems tend to underestimate sleep apnea severity and provide false negative results for some patients
with mild sleep apnea when compared to PSG [24–26]. Additional work on this finding is needed to
confirm or reject the hypothesis that LC can capture other physiological signs associated with distorted
breathing. Future work assessing our false positives with instrumentation more sensitive than gold
standard PSG may prove useful to confirm or refute the absence of a meaningful physiologic change
at those times. For example, PSG relies on human visual scoring for detection of hypopnea, such as
a 3-s visually detected change in frequency to score arousal and a 30% reduction of an uncalibrated
flow excursion with a variable baseline, both of which are used for gold standard determination
of hypopnea. Other known more sensitive tools, such as computer-assisted electroencephalogram
analysis or esophageal manometry, may or may not identify associations with meaningful physiologic
changes at times we classified as false positives.
5. Conclusions
The results of this pilot study showed the potential of a LC-based system to monitor sleep
disorders within the home under free-living conditions. The accuracy results of the system show that
we can identify patients with OSA without subject contact or maintenance of sensors with an accuracy
of 82.9% (sensitivity = 88.9%, specificity = 76.5%). Furthermore, we were able to demonstrate LC
deployability in the home environment, as indicated by the high ratings given by patients regarding
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several aspects of the device deployment, including ease of installation, bed stability, and effect of the
installed sensor on the feel of the bed. Given the results of this pilot study, additional multiple-night
studies with a larger sample size should be done to better characterize the accuracy, sensitivity, and
specificity of our method over time, correcting for limitations in the gold standard PSG, including the
first night effect and night-to-night variability in syndrome severity.
There are several advantages of the evaluated system over full PSG and HSAT devices. Our
non-contact sensor has a good sensitivity and does not require battery changes, maintenance or sensor
placement providing patients with an unobtrusive and easy-to-install sleep monitoring device that
continuously monitors patients’ sleep patterns, breathing, and automatically estimates the patient’s
OSA severity. The system evaluated in this study is cost-effective and can potentially benefit the
healthcare system since more patients might be diagnosed early, leading to substantial economical
savings through the prevention of serious health complications associated with untreated OSA.
Additional applications include long-term non-contact monitoring of sleep and breathing in pertinent
populations over time, such as military or pharmacologic trials.
Limitations of the study include the small sample size and the bias introduced by the gender
and age imbalance of the participants in the pilot study. However, despite the small sample size,
we were able to achieve good accuracy of the AHI estimation algorithm. We expect that results from
this preliminary study will help to guide further evaluations of LC-based sleep apnea testing within
homes and clinics.
Author Contributions: Conceptualization, P.G.J. and C.C.H.; methodology, P.G.J., C.C.H. and C.M.-L.; software,
C.M.-L., J.L. and C.C.H.; formal analysis, C.M.-L., P.G.J. and C.C.H.; system fabrication, P.G.J., J.L., C.H., J.C.
and C.C.H.; investigation, J.L., J.C., U.R., P.G.J. and C.H.; resources, J.L., U.R., P.G.J. and C.H.; data curation,
C.M.L. and J.L.; writing original draft preparation, C.M.-L.; writing review and editing, C.M.-L., P.G.J. and C.C.H.;
supervision, P.G.J. and C.C.H.; project administration, P.G.J.; funding acquisition, C.C.H. and P.G.J.
Funding: This research was funded by the National Institutes of Health (NIH) grant number NIH/NIHLB
2R01HL098621-04A1.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Peppard, P.; Young, T.; Barnet, J.H.; Palta, M.; Hagen, E.W.; Hla, K. Increased prevalence of sleep-disordered
breathing in adults. Am. J. Epidemiol. 2013, 12, 757–761. [CrossRef] [PubMed]
2. Lee, W.; Nagubadi, S.; Kryger, M.; Mokhlesi, B. Epidemiology of Obstructive Sleep Apnea: A Population-
based Perspective. Expert Rev. Respir. Med. 2008, 2, 349–364. [CrossRef] [PubMed]
3. Campbell, A.; Neill, A. Home Setup Polysomnography in the Assessment of Suspected Obstructive Sleep
Apnea. J. Sleep Res. 2011, 20, 207–213. [CrossRef] [PubMed]
4. Gibson, G. Obstructive sleep apnoea syndrome: Underestimated and undertreated. Br. Med. Bull. 2004,
72, 49–64. [CrossRef] [PubMed]
5. American Association of Sleep Medicine. Sleep-related breathing disorders in adults: Recommendations for
syndrome definition and measurement techniques in clinical research. Sleep 1999, 22, 667–689. [CrossRef]
6. Agnew, H.; Webb, W.; Williams, R. The first night effect: An EEG study of sleep. Psychophysiology 1966,
2, 263–266. [CrossRef] [PubMed]
7. Aurora, R.; Chowdhuri, S.; Ramar, K.; Bista, S.R.; Casey, K.R.; Lamm, C.I.; Kristo, D.A.; Mallea, J.M.;
Rowley, J.A.; Zak, R.S.; et al. The Treatment of Central Sleep Apnea Syndromes in Adults: Practice
Parameters with an Evidence-Based Literature Review and Meta-Analyses. Sleep 2012, 35, 17–40. [CrossRef]
[PubMed]
8. Centers for Medicare and Medicaid Services. National Coverage Determination for Continuous Positive
Airway Pressure Therapy for Obstructive Sleep Apnea. 2018. Available online: https://www.cms.gov/
medicare-coverage-database/ (accessed on 15 April 2018).
9. Epstein, L.; Kristo, D.; Strollo, P.; Friedman, N.; Malhotra, A.; Patil, S.P.; Ramar, K.; Rogers, R.; Schwab, R.J.;
Weaver, E.M.; et al. Clinical guideline for the evaluation, management and long-term care of obstructive
sleep apnea in adults. J. Clin. Sleep Med. 2009, 5, 263–276. [PubMed]
Biosensors 2019, 9, 90 14 of 14
10. Spicuzza, L.; Caruso, D.; Di Maria, D. Obstructive sleep apnoea syndrome and its management. Ther. Adv.
Chronic Dis. 2015, 6, 273–285. [CrossRef]
11. Brink, M.; Muller, C.; Schierz, C. Contact-free measurement of heart rate, respiration rate, and body
movements during sleep. Behav. Res. Methods 2006, 38, 511–521. [CrossRef] [PubMed]
12. Austin, D.; Beattie, Z.; Riley, T.; Adami, A.; Hagen, C.; Hayes, T. Unobtrusive classification of sleep and
wakefulness using load cells under the bed. In Proceedings of the 2012 Annual International Conference of
the IEEE Engineering in Medicine and Biology Society, San Diego, CA, USA, 28 August–1 September 2012;
pp. 5254–5257.
13. Beattie, Z.; Hagen, C.; Pavel, M.; Hayes, T. Classification of breathing events using load cells under the
bed. In Proceedings of the 2009 Annual International Conference of the IEEE Engineering in Medicine and
Biology Society, Minneapolis, MN, USA, 3–6 September 2009; pp. 3921–3924.
14. Beattie, Z.; Jacobs, P.; Riley, T.; Hagen, C. A time-frequency respiration tracking system using non-contact
bed sensors with harmonic artifact rejection. In Proceedings of the 2015 37th Annual International
Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Milan, Italy, 25–29 August
2015; pp. 8111–8114.
15. Beattie, Z.; Hayes, T.; Guilleminault, C.; Hagen, C. Accurate scoring of Apnea-Hypopnea Index using
a simple non-contact breathing sensor. J. Sleep Res. 2013, 22, 356–362. [CrossRef] [PubMed]
16. Arlotto, P.; Grimaldi, M.; Naeck, R.; Ginoux, J.M. An ultrasonic contactless sensor for breathing monitoring.
Sensors 2014, 14, 15371–15386. [CrossRef] [PubMed]
17. Behar, J.; Roebuck, A.; Domingos, J.S.; Gederi, E.; Clifford, G.D. A review of current sleep screening
applications for smartphones. Physiol. Meas. 2013, 34, 29–46. [CrossRef] [PubMed]
18. Nandakumar, R.; Gollakota, S.; Watson, N. Contactless sleep apnea detection on smartphones. In Proceedings
of the 13th Annual International Conference on Mobile Systems, Applications, and Services, Florence, Italy,
18–22 May 2015.
19. Mosquera-Lopez, C.; Leitschuh, J.; Condon, J.; Hagen, C.; Hanks, C.; Jacobs, P. In-Home Sleep Apnea
Severity Classification Using Contact-Free Load Cells and an AdaBoosted Decision Tree Algorithm. In
Proceedings of the 2018 40th Annual International Conference of the IEEE Engineering in Medicine and
Biology Society (EMBC), Honolulu, HI, USA, 18–21 July 2018; pp. 6044–6047.
20. Kapur, V.K.; Auckley, D.H.; Chowdhuri, S.; Kuhlmann, D.C.; Mehra, R.; Ramar, K.; Harrod, C.G. Clinical
Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of
Sleep Medicine Clinical Practice Guideline. J. Clin. Sleep Med. 2017, 13, 479–504. [CrossRef] [PubMed]
21. American Academy of Sleep Medicine (AASM). The International Classification of Sleep Disorders (ICSD);
AASM: Darien, IL, USA, 2004.
22. White, L.; Lyons, O.; Yadollahi, A.; Ryan, C.M.; Bradley, T.D. Night-to-night variability in obstructive sleep
apnea severity: Relationship to overnight rostral fluid shift. J. Clin. Sleep Med. 2015, 11, 149–156. [CrossRef]
[PubMed]
23. Stoberl, A.; Schwarz, E.; Haile, S.; Turnbull, C.D.; Rossi, V.A.; Stradling, J.R.; Kohler, M. Night-to-night
variability of obstructive sleep apnea. J. Sleep Res. 2017, 26, 782–788. [CrossRef] [PubMed]
24. Aurora, R.; Swartz, R.; Punjabi, N. Misclassification of OSA severity with automated scoring of home sleep
recordings. Chest 2015, 147, 719–727. [CrossRef] [PubMed]
25. Bianchi, M.; Goparaju, B. Potential underestimation of sleep apnea severity by at-home kits: Rescoring
in-laboratory polysomnography without sleep staging. J. Clin. Sleep Med. 2017, 13, 551–555. [CrossRef]
[PubMed]
26. Ward, K.; McArdle, N.; James, A. A Comprehensive Evaluation of a Two-Channel Portable Monitor to “Rule
in” Obstructive Sleep Apnea. J. Clin. Sleep Med. 2015, 11, 433–444. [CrossRef]
c© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
